Biotech · Public company · Pittsburgh, PA, US
Lipella Pharmaceuticals Inc.
Ticker LIPO · SEC CIK 0001347242
Track this companyFree. Adds Lipella Pharmaceuticals Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline2
- LP-10Phase 2 · Hemorrhagic CystitisClinicalTrials.gov · fetched Nov 12, 2026
- LP-10 (Liposomal Tacrolimus)Phase 2 · Oral Lichen PlanusClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Evaluating LP-10 in Subjects With OLPPHASE2 · UNKNOWN · started Jul 1, 2024ClinicalTrials.gov NCT06233591 · fetched Nov 12, 2026
- Phenotyping Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by Intravesical Contrast Enhanced - Magnetic Resonance Imaging (ICE-MRI) Bladder Permeability AssayCOMPLETED · started Mar 29, 2023ClinicalTrials.gov NCT05811377 · fetched Nov 12, 2026
- The Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic CystitisPHASE2 · COMPLETED · started Oct 1, 2020ClinicalTrials.gov NCT03129126 · fetched Nov 12, 2026
SEC filings12
- 8-K · FORM 8-KSEC EDGAR · filed Jul 15, 2026 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Mar 31, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 4, 2026 · fetched Nov 12, 2026
- 10-Q · FORM 10QSEC EDGAR · filed Nov 14, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 21, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Oct 9, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 18, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 14, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 25, 2025 · fetched Nov 12, 2026
- 8-K · FORM 8-KSEC EDGAR · filed Jun 20, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 16, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 16, 2025 · fetched Nov 12, 2026